The non-mechanical micropump segment by product type is estimated to lead the market growth during the forecast period.

According to a new market research study of “North America Micropump Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Product, Material, Application, End User and Country.” The North America micropump market is expected to reach US$ 2,294.16 million by 2028 from as estimated value of US$ 678.11 million in 2021; it is likely to grow at a CAGR of 19.0% from 2021 to 2028. The report highlights trends prevailing in the North America micropump market and the factors driving market along with those that act as hindrances. 

In recent years, controlled release of drugs faced challenges such as the release of a suitable quantity of drugs at the right time with the least invasiveness and raised demand for advanced drug delivery devices. The emergence of micro-electro-mechanical systems (MEMS) that combine mechanical and electrical components provides a solution to overcome these challenges. The rising adoption of miniaturized medical devices has helped reshape the medical device industry. Owing to the rising healthcare costs and the shift to home-based outpatient care, the demand for smaller, lighter, and portable products has increased tremendously. The miniaturization of a medical device can be achieved in various ways—one of the most important is through micropumps. Micropumps are associated with lower production costs, fewer leaks, decreased power consumption, and increased accuracy owing to the controlled flow of fluids and delivery of drug dosage into the body. They can handle extremely small volumes of liquid efficiently. Micropumps are being developed for a variety of medical applications including transdermal insulin delivery, blood transportation through artificial hearts, injection of glucose and drugs, hormone treatment, and pain and wound-care management. Additionally, manufacturers are releasing a wide range of micropumps to cater to the rising demand of the medical device industry.

North America has been witnessing an increasing number of COVID-19 cases since its outbreak. Several measures are being taken to contain the disease and prevent the transmission. The exorbitant number of COVID-19 cases have resulted in cancelation of doctor's appointment, decrease in demand for elective neurosurgery, and disruption in supply chain due to long period of lockdown. In the US, many doctors, hospitals, and other healthcare facilities are delaying or canceling the cancer procedures, surgeries, and sometimes screenings or other treatments, if they are not considered urgent, emergencies, or otherwise indicated for life-threatening conditions. More research is being conducted on COVID-19 vaccines than on any other disease. Pharmaceutical companies are halting ongoing studies and delaying the launch of new trials. Therefore, it is likely to affect micropumps market owing to above mention points.

The North America micropump market, by product type is segmented into mechanical micropump, syringe pump, piezoelectric micropump, peristaltic pump, and non-mechanical micropump. The North America micropump market based on material is segmented into silicon, polymer, and glass. The North America micropump market by application, is segmented into medical equipment & devices, clinical & analytical lab, pharmaceuticals, biotechnology, and others. The North America micropump market by end user, is segmented into hospitals & diagnostic centers, biotechnology & pharmaceutical companies, and academic & research institutes. Geographically, the North America micropump market can be sub-segmented into U.S. Mexico and Canada.

Advanced Microfluidics, Microfluidica, LLC, Alldoo Micropump Co.,Ltd, Servoflo Corporation, TOPS INDUSTRY AND TECHNOLOGY CO. LTD, World Precision Instruments, Xavitech, Calon Cardio-Technology Ltd, Takasago Electric, Inc. and Medtronic are among the leading companies operating in the North America micropump market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com